GMO Emerging Markets Fund Class R6
GEMNX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Boston MA 02110 New York NY United States of America 10282
- IPO Date
- Mar 31, 2020
- CIK
- 0000772129
- Website
- gsam.com
- Similar Companies
- Business
- GMO Emerging Markets Fund Class R6 (GEMNX) is an open-end mutual fund that seeks total return by investing primarily in equities of companies tied economically to emerging (non-developed) markets; it measures performance against the MSCI Emerging Markets Index. The fund employs a systematic equity approach utilizing a multi-factor valuation model, complemented by momentum signals and corporate alerts, to identify undervalued securities amid short-term market inefficiencies driven by irrational investor behavior and imperfect information flows. Key sectors include financials (22.7%), information technology (18.4%), consumer discretionary (13.3%), and industrials (13.3%); top holdings as of July 31, 2025, feature Taiwan Semiconductor Manufacturing Co Ltd (9.3%), Tencent Holdings Ltd (4.4%), and OTP Bank Nyrt (3.0%), with significant geographic exposures to China (26.1%), Taiwan (22.1%), and South Korea (12.3%). The Class R6 share class (ticker: GEMNX), with a net expense ratio of 1.03%, was incepted on March 31, 2020, as part of the broader GMO Emerging Markets Fund launched on December 9, 1993; the fund manages total assets of approximately $431-463 million USD and is available to U.S. investors with no minimum initial investment. GMO LLC, the fund's investment manager founded in 1977 and headquartered in Boston, Massachusetts, oversees the strategy through its Systematic Equity team, led by portfolio managers George Sakoulis (joined GMO in 2020, rejoined as Head of Investment Teams) and Warren Chiang, CFA (joined in 2015). Recent developments include sustained portfolio manager continuity with Sakoulis assuming expanded leadership responsibilities upon rejoining in 2020 amid GMO's strategic management team enhancements, alongside the firm's ongoing emphasis on emerging markets opportunities reinforced by reiterations of compelling valuations in related emerging market debt strategies in 2024-2025.